▶ 調査レポート

卵巣がん遺伝子治療の世界市場(~2026年)

• 英文タイトル:Global Gene Therapy for Ovarian Cancer Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。卵巣がん遺伝子治療の世界市場(~2026年) / Global Gene Therapy for Ovarian Cancer Market Size, Status and Forecast 2020-2026 / MRC2-11QY12020資料のイメージです。• レポートコード:MRC2-11QY12020
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、94ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は卵巣がん遺伝子治療のグローバル市場について調査・分析したレポートです。種類別(静脈内、腫瘍内、腹腔内)市場規模、用途別(卵巣がん(詳細不明)、再発卵巣上皮がん、プラチナ耐性卵巣がん)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別卵巣がん遺伝子治療の競争状況、市場シェア
・世界の卵巣がん遺伝子治療市場:種類別市場規模 2015年-2020年(静脈内、腫瘍内、腹腔内)
・世界の卵巣がん遺伝子治療市場:種類別市場規模予測 2021年-2026年(静脈内、腫瘍内、腹腔内)
・世界の卵巣がん遺伝子治療市場:用途別市場規模 2015年-2020年(卵巣がん(詳細不明)、再発卵巣上皮がん、プラチナ耐性卵巣がん)
・世界の卵巣がん遺伝子治療市場:用途別市場規模予測 2021年-2026年(卵巣がん(詳細不明)、再発卵巣上皮がん、プラチナ耐性卵巣がん)
・北米の卵巣がん遺伝子治療市場分析:米国、カナダ
・ヨーロッパの卵巣がん遺伝子治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの卵巣がん遺伝子治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の卵巣がん遺伝子治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの卵巣がん遺伝子治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Takara Bio、VBL Therapeutics、CELSION、Targovax
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor, and stromal ovarian tumor are some of the less common types. It is the seventh most common cancer in women globally and 18th most common cancer overall. The ovarian cancer immunotherapies market has already got some commercially successful chemotherapy products. However, chemotherapy often involves a combination of two or more drugs, given intravenously every 3-4 weeks, and mostly associated with long-lasting side/adverse effects. Various studies have shown that chemotherapy can damage the blood-producing cells of the bone marrow, resulting in blood-related complications.
Gene therapy is expected to be one of the next big paradigm shift in pharmacology due to the extensive on-going research studies, both at academic and industry level. Gene therapy is one of the most exciting approaches for the treatment of ovarian cancer. Replacement gene therapy is gaining attention as it has the potential to cure ovarian cancer and can be used as a promising option for long-lasting treatment.

Market Analysis and Insights: Global Gene Therapy for Ovarian Cancer Market
The global Gene Therapy for Ovarian Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Gene Therapy for Ovarian Cancer Scope and Market Size
Gene Therapy for Ovarian Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy for Ovarian Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Takara Bio
VBL Therapeutics
CELSION
Targovax

Market segment by Type, the product can be split into
Intravenous
Intratumoral
Intraperitoneal
Market segment by Application, split into
Ovarian Cancer (unspecified)
Recurrent Ovarian Epithelial Cancer
Platinum-Resistant Ovarian Cancer

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gene Therapy for Ovarian Cancer Revenue
1.4 Market by Type
1.4.1 Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Intravenous
1.4.3 Intratumoral
1.4.4 Intraperitoneal
1.5 Market by Application
1.5.1 Global Gene Therapy for Ovarian Cancer Market Share by Application: 2020 VS 2026
1.5.2 Ovarian Cancer (unspecified)
1.5.3 Recurrent Ovarian Epithelial Cancer
1.5.4 Platinum-Resistant Ovarian Cancer
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Gene Therapy for Ovarian Cancer Market Perspective (2015-2026)
2.2 Global Gene Therapy for Ovarian Cancer Growth Trends by Regions
2.2.1 Gene Therapy for Ovarian Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gene Therapy for Ovarian Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Gene Therapy for Ovarian Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gene Therapy for Ovarian Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Gene Therapy for Ovarian Cancer Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy for Ovarian Cancer Players by Market Size
3.1.1 Global Top Gene Therapy for Ovarian Cancer Players by Revenue (2015-2020)
3.1.2 Global Gene Therapy for Ovarian Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Gene Therapy for Ovarian Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio
3.2.1 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gene Therapy for Ovarian Cancer Revenue in 2019
3.3 Gene Therapy for Ovarian Cancer Key Players Head office and Area Served
3.4 Key Players Gene Therapy for Ovarian Cancer Product Solution and Service
3.5 Date of Enter into Gene Therapy for Ovarian Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Gene Therapy for Ovarian Cancer Historic Market Size by Type (2015-2020)
4.2 Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020)
5.2 Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Gene Therapy for Ovarian Cancer Market Size (2015-2020)
6.2 Gene Therapy for Ovarian Cancer Key Players in North America (2019-2020)
6.3 North America Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020)
6.4 North America Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020)

7 Europe
7.1 Europe Gene Therapy for Ovarian Cancer Market Size (2015-2020)
7.2 Gene Therapy for Ovarian Cancer Key Players in Europe (2019-2020)
7.3 Europe Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020)
7.4 Europe Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020)

8 China
8.1 China Gene Therapy for Ovarian Cancer Market Size (2015-2020)
8.2 Gene Therapy for Ovarian Cancer Key Players in China (2019-2020)
8.3 China Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020)
8.4 China Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020)

9 Japan
9.1 Japan Gene Therapy for Ovarian Cancer Market Size (2015-2020)
9.2 Gene Therapy for Ovarian Cancer Key Players in Japan (2019-2020)
9.3 Japan Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020)
9.4 Japan Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Gene Therapy for Ovarian Cancer Market Size (2015-2020)
10.2 Gene Therapy for Ovarian Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020)

11 India
11.1 India Gene Therapy for Ovarian Cancer Market Size (2015-2020)
11.2 Gene Therapy for Ovarian Cancer Key Players in India (2019-2020)
11.3 India Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020)
11.4 India Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Gene Therapy for Ovarian Cancer Market Size (2015-2020)
12.2 Gene Therapy for Ovarian Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020)
12.4 Central & South America Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Takara Bio
13.1.1 Takara Bio Company Details
13.1.2 Takara Bio Business Overview
13.1.3 Takara Bio Gene Therapy for Ovarian Cancer Introduction
13.1.4 Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2015-2020))
13.1.5 Takara Bio Recent Development
13.2 VBL Therapeutics
13.2.1 VBL Therapeutics Company Details
13.2.2 VBL Therapeutics Business Overview
13.2.3 VBL Therapeutics Gene Therapy for Ovarian Cancer Introduction
13.2.4 VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2015-2020)
13.2.5 VBL Therapeutics Recent Development
13.3 CELSION
13.3.1 CELSION Company Details
13.3.2 CELSION Business Overview
13.3.3 CELSION Gene Therapy for Ovarian Cancer Introduction
13.3.4 CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2015-2020)
13.3.5 CELSION Recent Development
13.4 Targovax
13.4.1 Targovax Company Details
13.4.2 Targovax Business Overview
13.4.3 Targovax Gene Therapy for Ovarian Cancer Introduction
13.4.4 Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2015-2020)
13.4.5 Targovax Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Gene Therapy for Ovarian Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Gene Therapy for Ovarian Cancer Revenue
Table 3. Ranking of Global Top Gene Therapy for Ovarian Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Intravenous
Table 6. Key Players of Intratumoral
Table 7. Key Players of Intraperitoneal
Table 8. Global Gene Therapy for Ovarian Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Gene Therapy for Ovarian Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Gene Therapy for Ovarian Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Gene Therapy for Ovarian Cancer Market Share by Regions (2015-2020)
Table 12. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Gene Therapy for Ovarian Cancer Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Gene Therapy for Ovarian Cancer Market Growth Strategy
Table 18. Main Points Interviewed from Key Gene Therapy for Ovarian Cancer Players
Table 19. Global Gene Therapy for Ovarian Cancer Revenue by Players (2015-2020) (Million US$)
Table 20. Global Gene Therapy for Ovarian Cancer Market Share by Players (2015-2020)
Table 21. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2019)
Table 22. Global Gene Therapy for Ovarian Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Gene Therapy for Ovarian Cancer Product Solution and Service
Table 25. Date of Enter into Gene Therapy for Ovarian Cancer Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020) (Million US$)
Table 28. Global Gene Therapy for Ovarian Cancer Market Size Share by Type (2015-2020)
Table 29. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2021-2026)
Table 30. Global Gene Therapy for Ovarian Cancer Market Size Share by Application (2015-2020)
Table 31. Global Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020) (Million US$)
Table 32. Global Gene Therapy for Ovarian Cancer Market Size Share by Application (2021-2026)
Table 33. North America Key Players Gene Therapy for Ovarian Cancer Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Gene Therapy for Ovarian Cancer Market Share (2019-2020)
Table 35. North America Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020) (Million US$)
Table 36. North America Gene Therapy for Ovarian Cancer Market Share by Type (2015-2020)
Table 37. North America Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020) (Million US$)
Table 38. North America Gene Therapy for Ovarian Cancer Market Share by Application (2015-2020)
Table 39. Europe Key Players Gene Therapy for Ovarian Cancer Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Gene Therapy for Ovarian Cancer Market Share (2019-2020)
Table 41. Europe Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Gene Therapy for Ovarian Cancer Market Share by Type (2015-2020)
Table 43. Europe Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Gene Therapy for Ovarian Cancer Market Share by Application (2015-2020)
Table 45. China Key Players Gene Therapy for Ovarian Cancer Revenue (2019-2020) (Million US$)
Table 46. China Key Players Gene Therapy for Ovarian Cancer Market Share (2019-2020)
Table 47. China Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020) (Million US$)
Table 48. China Gene Therapy for Ovarian Cancer Market Share by Type (2015-2020)
Table 49. China Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020) (Million US$)
Table 50. China Gene Therapy for Ovarian Cancer Market Share by Application (2015-2020)
Table 51. Japan Key Players Gene Therapy for Ovarian Cancer Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Gene Therapy for Ovarian Cancer Market Share (2019-2020)
Table 53. Japan Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Gene Therapy for Ovarian Cancer Market Share by Type (2015-2020)
Table 55. Japan Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Gene Therapy for Ovarian Cancer Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Gene Therapy for Ovarian Cancer Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Gene Therapy for Ovarian Cancer Market Share (2019-2020)
Table 59. Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Gene Therapy for Ovarian Cancer Market Share by Type (2015-2020)
Table 61. Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Gene Therapy for Ovarian Cancer Market Share by Application (2015-2020)
Table 63. India Key Players Gene Therapy for Ovarian Cancer Revenue (2019-2020) (Million US$)
Table 64. India Key Players Gene Therapy for Ovarian Cancer Market Share (2019-2020)
Table 65. India Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020) (Million US$)
Table 66. India Gene Therapy for Ovarian Cancer Market Share by Type (2015-2020)
Table 67. India Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020) (Million US$)
Table 68. India Gene Therapy for Ovarian Cancer Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Gene Therapy for Ovarian Cancer Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Gene Therapy for Ovarian Cancer Market Share (2019-2020)
Table 71. Central & South America Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Gene Therapy for Ovarian Cancer Market Share by Type (2015-2020)
Table 73. Central & South America Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Gene Therapy for Ovarian Cancer Market Share by Application (2015-2020)
Table 75. Takara Bio Company Details
Table 76. Takara Bio Business Overview
Table 77. Takara Bio Product
Table 78. Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2015-2020) (Million US$)
Table 79. Takara Bio Recent Development
Table 80. VBL Therapeutics Company Details
Table 81. VBL Therapeutics Business Overview
Table 82. VBL Therapeutics Product
Table 83. VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2015-2020) (Million US$)
Table 84. VBL Therapeutics Recent Development
Table 85. CELSION Company Details
Table 86. CELSION Business Overview
Table 87. CELSION Product
Table 88. CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2015-2020) (Million US$)
Table 89. CELSION Recent Development
Table 90. Targovax Company Details
Table 91. Targovax Business Overview
Table 92. Targovax Product
Table 93. Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2015-2020) (Million US$)
Table 94. Targovax Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy for Ovarian Cancer Market Share by Type: 2020 VS 2026
Figure 2. Intravenous Features
Figure 3. Intratumoral Features
Figure 4. Intraperitoneal Features
Figure 5. Global Gene Therapy for Ovarian Cancer Market Share by Application: 2020 VS 2026
Figure 6. Ovarian Cancer (unspecified) Case Studies
Figure 7. Recurrent Ovarian Epithelial Cancer Case Studies
Figure 8. Platinum-Resistant Ovarian Cancer Case Studies
Figure 9. Gene Therapy for Ovarian Cancer Report Years Considered
Figure 10. Global Gene Therapy for Ovarian Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Gene Therapy for Ovarian Cancer Market Share by Regions: 2020 VS 2026
Figure 12. Global Gene Therapy for Ovarian Cancer Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Gene Therapy for Ovarian Cancer Market Share by Players in 2019
Figure 15. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy for Ovarian Cancer Revenue in 2019
Figure 17. North America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed